Wake Forest Baptist Medical Center, Winston-Salem, NC
Resident, Department of Radiation Oncology
W. Robert Lee, MD and Kevin P. McMullen, MD, Program Directors
Carilion Roanoke Memorial Hospital, Roanoke, Virginia
Transitional Medicine Internship
William Erwin, MD, Program Director
Wake Forest University School of Medicine, Winston-Salem, NC
Doctor of Medicine, May 2003
Wake Forest University, Winston-Salem, NC Bachelor of Science, 1999, Magna Cum Laude
Gonzaga College High School, Washington, D.C.
Roentgen Resident/Fellow Research Award Radiological Society of North America, 2007
President, Carilion Roanoke Memorial Transitional Residents, 2003-2004
M. Robert Cooper Oncology Excellence in Cancer Research Award Recipient, 2003
Clinical honors in Radiation Oncology, WFU School of Medicine 2002
WFU School of Medicine Vice President's Academic Scholarship, 1999-2003
Page Acree Scholarship for International Research, Wake Forest University, 1999
Magna Cum Laude graduate -Wake Forest University 2003
Early Assurance Acceptance -WFU School of Medicine, 1998
Guy T. Carswell Scholar, Wake Forest University, 1997-1999
Carl Rowan Scholar, Wake Forest University, 1995-1999
Mortar Board National Honor Society, 1997-1999
Omicron Delta Kappa National Honor Society, 1997-1999
Alpha Epsilon Delta National Pre-Medical Honor Society, 1996-1999
Golden Key National Honor Society, 1998-1999
Reynolds Health Center Volunteer Service Award, 1997
President Thomas L. Dooley "Man for Others" Award, 1995
Seattle Prostate Institute: Ultrasound Guided Transperineal Brachytherapy for Early Stage Prostate Cancer Resident's Course, September 2006
Proficiencies: IMRT, IGRT, HDR, LDR, Gliasite, 4D treatment planning, Gamma Knife, and extracranial stereotactic radiosurgery. Pinnacle, GE, Eclipse, Nuc1etron, and Variseed treatment planning systems.
Wake Forest University, Department of Radiation Oncology
Supervisedby Dr. William Blackstock
Gastrointestinal Malignancies
Novel Management Strategies of Pancreatic Cancer
Wake Forest University, Department of Radiation Oncology
Supervised by Dr. Edward G. Shaw
Cognitive Effects of Brain Tumor Patients Receiving Radiation
J. Butler, Jr., M.D., D. Case, Ph.D., G. Lesser, M.D., V. Stieber, M.D., K. McMullen, M.D., R McQuellon, Ph.D., D. Moose, M.D., S. Rapp, Ph.D. M. Naughton, Ph.D., N. Avis, Ph.D. and E. Shaw, M.D. A Phase III, Double Blind, Prospective Randomized Clinical Trial of Effect of d-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy. Int J Radiat Oncol Biol Phys. Sep 2007; [Epub ahead of print]
John Gleason, Jr., B.A., Douglas Case, Ph.D., Stephen Rapp, Ph.D., Michelle Naughton, Ph.D., Edward Ip, Ph.D., Jerome Butler, M.D., Kevin McMullen, M.D., Volker Stieber, M.D., Paul Saconn, B.A., and Edward G. Shaw, M.D. Symptom Clusters in Newly-Diagnosed Brain Tumor Patients. Journal of Supp Oncology, Volume 5, Number, October 2007.</p.
Wentworth S, Butler J, and Blackstock A. Integrating Anti-Angiogenic Therapy into the Treatment of Locally Advanced Pancreatic Cancer. Advances in Pancreatic Cancer, Vol 1, No.1, September 2007.
Suzanne Russo MD, Jerome Butler, M.D., Roger Ove MD PhD, and A. William Blackstock MD. Management of Locally Advanced Pancreatic Adenocarcinoma. Seminars in Oncology, Volume 34, Issue 4, 327-334, August 2007.
Butler JM, Rapp SR, Shaw EG: Managing the Cognitive Effects of Brain Tumor Radiation Therapy; In (eds): Current Treatment Options in Oncology 2006, 7:517-523.
A. William Blackstock M.D., Coty Ho, M.D., Jerome Butler, M.D., June Fletcher-Steede, B.A., L. Douglas Case, Ph.D. William Hinson, Ph.D. and Antonius A. Miller, M.D. Phase Ia/Ib Chemoradiation Trial of Gemcitabine and Dose-escalated Thoracic Radiation in Patients with Stage III AlB Non Small Cell Lung Cancer. Journal of Thoracic Oncology, Vol 1, Number 5, June 2006.
Girish Mishra, MD, Jerome Butler, MD, Coty Ho, MD, Susan Melin, MD, L. Douglas Case, PhD, Russell Howerton, Edward Levine, MD, and A. William Blackstock, MD. Phase II Trial of Induction Gemcitabine/CPT -11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer. American Journal of Clinical Oncology, Vol 28, Number 4, August 2005.
Boles CA, Butler J, Lee JA, Reedy ML, Martin DF. Magnetic resonance characteristics of medial plica of the knee: correlation with arthroscopic resection. J Comput Assist Tomogr. 2004 May-Jun;28(3):397-401.
Blackstock, A.W., Melin, S., Lesser, G., Butler, J., Patton, S., et al. IrinotecaniGemcitabine Followed by Twice Weekly Gemcitabine and Radiation for the Treatment of Locally Advanced Pancreatic Cancer. Oncology, Vol 16, No 5, Supplement 5, May 2002.
Butler JM, Farmer MR, Blackstock AW: Treatment Planning for Gastrointestinal Malignancies; in Watson G, Tobler M (eds): Bentel's Radiation Therapy Planning: 3rd Edition. McGraw-Hill Book Company. In Press, Expected 2007
J.M. Butler, B. E. Lally, R. D'Agostino, J. J. Urbanic, S. Wentworth, E. Paskett, A. W. Blackstock. Impact of Race and Marital Status on Survival and Stage at Presentation for Patients with Colorectal Cancer: An Analysis of Data from the Surveillance, Epidemiology, and End-Results (SEER) program
- ASTRO 48th Annual Meeting, Philadelphia, PA 10/2006
- North Carolina Oncology Association / South Carolina Oncology Society Joint Fall 2007 Membership Meeting, Charleston, SC
Lally BE, Urbanic JJ, Butler JM, Wentworth S, Thomas CR, Blackstock AW. Outcomes of patients with limitedstage small cell lung cancer treated with radiotherapy: Analysis of data from the Surveillance, Epidemiology, and End-Results (SEER) program. ASTRO 48th Annual Meeting, Philadelphia, PA 10/2006
S. Wentworth, B. Lally, J. Butler, 1. Urbanic, A. Blackstock. Impact of Race on Survival and Radiotherapy Use in Patients with Non-Metastatic Rectal Cancer: Analysis of Data from the Surveillance, Epidemiology and End-Results (SEER) Program; ASTRO 48th Annual Meeting, Philadelphia, PA 10/2006
J. Butler, Jr., M.D., D. Case, Ph.D., G. Lesser, M.D., V. Stieber, M.D., K. McMullen, M.D., R McQuellon, Ph.D., D. Moose, M.D., S. Rapp, Ph.D. M. Naughton, Ph.D., N. Avis, Ph.D. and E. Shaw, M.D. A Phase III, Double Blind, Prospective Randomized Clinical Trial of Effect of d-threo-methylphenidate HCI (d-MPH) on Quality of Life in Brain TumorPatients Receiving Radiation Therapy. ASTRO, 47th Annual Meeting, Denver, CO 10/2005
Butler, Jerome, B.S., Outcomes among African-Americans and non African-American patients with advanced NSCLC receiving chemotherapy. A report from the Cancer and Leukemia Group B (CALGB); Oral Presentation, North Carolina Department Health Human Services Cancer Advisory Meeting; Raleigh, Durham, April 2002. Poster Presentation at 8th Biennial Symposium on Minorities, the Medically Underserved & Cancer in Washington, D.C. February 2002
W. T. Kearns, W. H. Hinson, C. J. Hampton, J. M. Butler, J. J. Urbanic, D. Starnes, A. F. deGuzman, V. W. Stieber. Radiation Safety Issues with PETICT Simulation for Stereotactic Body Radiotherapy; Poster Presentation ASTRO 48th Annual Meeting, Phil, PA 10/2006
J. J. Urbanic, W. H. Hinson, V. W. Stieber, J. M. Butler, W. T. Kearns, C. J. Hampton, A. W. Blackstock. Heterogeneity Corrections in Stereotactic Body Radiotherapy (54 Gy in 3 Fractions) for Lung Tumors Significantly Alter Delivered Dose; Poster Presentation ASTRO 48th Annual Meeting, Phil, PA 10/2006
John Gleason, Jr., B.A., Douglas Case, Ph.D., Stephen Rapp, Ph.D., Michelle Naughton, Ph.D., Edward Ip, Ph.D., Jerome Butler, M.D., Kevin McMullen, M.D., Volker Stieber, M.D., Paul Saconn, B.A., and Edward G. Shaw, M.D. Symptom Clusters in Newly-Diagnosed Brain Tumor Patients. Poster Presentation 2006 ASCO Annual Meeting; Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 8587
B.E. Lally, J. Butler, G. Mishra, B. Pasket and A.W. Blackstock. The Impact ofEthnicity on Survival for Patients with Pancreatic Cancer: A SEER Analysis. Poster Presentation, 2006 Gastrointestinal Cancer Symposium (GI ASCO), San Francisco, CA, January 2006.
Jerome Butler, Jr. M.D., Mabe Aklilu M.D., Coty Ho M.D., Edward Levine M.D., John Stewart M.D. and A. William Blackstock M.D. A Phase I Dose-Escalating Study of Induction GemcitabinelPremetrexed followed by Premetrexed and Concurrent Upper Abdominal Radiation Therapy in Patients with Locally Advanced Pancreatic Cancer. Poster Presentation at Lilly Oncology Young Investigators Meeting in San Antonio, Texas, April 2005
Hess, SM, Butler, J., Anderson, J., Blackstock, A.W. The effect ofBBR3464 on colon cancer cells. Poster Presentation, Radiation Research Meeting, Reno, Nevada, April 2002
Boles, CA, M.D., Martin, DF, M.D., Butler, J, B.S., MR Imaging of Medial Synovial Plicae: Characteristics with Arthroscopic Correlation. Annual Meeting of the Society of Skeletal Radiology, February 2001
Butler, Jerome, B.S., Evans, Robert, PhD., Is Health Care Y2K Compliant? A Study of Managed Health Care Systems vs. Socialized Medicine. Presented to Wake Forest University Page Acree Committee on International Research,8/1999
American Society of Therapeutic Radiation Oncology (ASTRO)
American Brachytherapy Society (ABS)
American College of Radiology (ACR)
Radiation Research Society (RRS)
Association of Residents in Radiation Oncology (ARRO)
Radiologic Society of North America (RSNA)
Alpha Phi Alpha Fraternity Incorporated
State of North Carolina Medical License
Married, 1 child
